Related Experiment Videos
Hepatic porphyria induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the mouse
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Processus organisationnels et pratiques cliniques pour la gestion de la douleur chronique en soins primaires : une offre de service découlant du plan d'action en douleur chronique 2021-2026 ministériel du Québec, Canada.
Canadian journal of pain = Revue canadienne de la douleur·2026
Assessment of an AI-based tool for population-wide collection of placental morphological data.
European journal of obstetrics, gynecology, and reproductive biology·2024
17 years' experience of surgical management of thoracic outlet syndrome at a district general hospital.
Annals of the Royal College of Surgeons of England·2023
Modulation of dopamine tone induces frequency shifts in cortico-basal ganglia beta oscillations.
Nature communications·2021
Where is the nerve? Review of operation note documentation practice for inguinal hernia repair.
Annals of the Royal College of Surgeons of England·2021
Is heat acclimation able to increase whole-body sensitivity to insulin?
Research communications in chemical pathology and pharmacology·1994
Vasodilator effects of clonidine on the mesenteric arterial beds in normotensive and spontaneously hypertensive rats.
Research communications in chemical pathology and pharmacology·1994
Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis.
Research communications in chemical pathology and pharmacology·1994
Copper cytotoxicity impairs DNA synthesis but not protein phosphorylation upon growth stimulation in LEC mutant rat.
Research communications in chemical pathology and pharmacology·1994
Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.
Research communications in chemical pathology and pharmacology·1994
Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
Research communications in chemical pathology and pharmacology·1994